Honey bees (Apis mellifera L.) play an important ecological and economical role. Recently, Europe and the US have reported an increase in honey bee colony losses owing to several factors. Several possible causes for colony losses have been proposed, including exposure to pesticides such as agrochemicals for crop protection and pesticides for veterinarian use inside the hive. Mexico lacks reports about pesticide residues in hive products (honey, beeswax, pollen, propolis and royal jelly). This study presents the analysis of 93 agricultural pesticide residues found in honey and beeswax samples from Yucatan, the main area of beekeeping in Mexico, and from hives in Northeastern and Central Mexico, as well as in commercial wax samples. The number and concentrations of pesticides found are dependent of region. Yucatan hive samples had the lowest levels of agrochemicals. In Yucatan, the main agrochemical found in honey was the fungicide phenylphenol, while in wax combs, the agrochemicals found in the highest concentrations were the phenylphenol and the organochlorine 2,4′-DDT. In Northeastern Mexico, the main pesticides detected in wax and/or honey were malathion, chlorpyrifos, phenylphenol and thiabendazole, whereas in Central Mexico, the most common residues were chlorpyrifos and imidacloprid. Commercial wax showed low levels of pesticides residues. Malathion concentration in one sample of honey taken from Northeastern Mexico exceeded the European Maximum Residue Levels (MRL = 0.05 mg/kg).
Some international organisations established maximum residue limits (MRLs) in food to protect human health. Mexico lacks regulations in this matter, affecting national and international trade from agroindustry. The aim of this study was to diagnose pesticide residues in oranges from Nuevo Leon, México, in citrus orchards. In May 2014, 100 orange fruit samples were taken randomly from orchards and subjected to analysis for 93 pesticides at residual level by GC/QQQ-MS and LCQ-TOF-MS. Results showed the presence of 15 pesticide residues in the samples. The comparison of the residual levels of pesticides found in orange samples among the MRLs allowed by USA, EU and Japanese regulations demonstrated that all samples were below MRLs issued by USA and Japan. Some orange samples were above MRLs issued by the EU. This provides a basis to establish strategies in order to satisfy International Standards to protect human health and encourage Food Safety in Mexico.
1 September 2019 in Atmospheric Pollution Research
Preliminary bioassay-guided fractionation was performed to identify cytotoxic compounds from Hechtia glomerata, a plant that is used in Mexican ethnomedicine. Organic and aqueous extracts were prepared from H. glomerata’s leaves and evaluated against two cancer cell lines. The CHCl3/MeOH (1:1) active extract was fractionated, and the resulting fractions were assayed against prostate adenocarcinoma PC3 and breast adenocarcinoma MCF7 cell lines. Active fraction 4 was further analyzed by high-performance liquid chromatography–quadrupole time-of-flight–mass spectrometry analysis to identify its active constituents. Among the compounds that were responsible for the cytotoxic effects of this fraction were flavonoids, phenolic acids, and aromatic compounds, of which p-coumaric acid (p-CA) and its derivatives were abundant. To understand the mechanisms that underlie p-CA cytotoxicity, a microarray assay was performed on PC3 cells that were treated or not with this compound. The results showed that mitogen-activated protein kinases (MAPKs) that regulate many cancer-related pathways were targeted by p-CA, which could be related to the reported effects of reactive oxygen species (ROS). A molecular docking study of p-CA showed that this phenolic acid targeted these protein active sites (MAPK8 and Serine/Threonine protein kinase 3) at the same binding site as their inhibitors. Thus, we hypothesize that p-CA produces ROS, directly affects the MAPK signaling pathway, and consequently causes apoptosis, among other effects. Additionally, p-CA could be used as a platform for the design of new MAPK inhibitors and re-sensitizing agents for resistant cancers.